UnitedHealth (UNH) reported Q4 FY 2020 earnings of $2.52 per share (versus $3.90 per share in Q4 FY 2019), beating analysts’ consensus estimate of $2.39 per share.
The company’s quarterly revenues amounted to $65.467 bln (+7.5% y/y), roughly in line with analysts’ consensus estimate of $64.979 bln.
The company also reaffirmed its guidance for FY21, projecting EPS of $17.75-18.25 versus analysts’ consensus estimate of $18.19.
UNH fell to $352.00 (-0.05%) in pre-market trading.